Canadian HTA Ups Industry Fees To Fund Review Process Improvements
Canada’s health technology appraisal body is to increase its industry fees well beyond inflation for conducting reviews and scientific advice. It says it will also improve its drug reimbursement review process.
You may also be interested in...
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.
The IGBA has welcomed Mexican pharmaceutical industry association ANAFAM as an associate member.
The UK pharmaceutical industry association, the ABPI, would like to see its own system strengthened to improve reporting of payments to health care professionals and organizations.